Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

about

Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21.Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth.

P2860

Q47101995-B7C40A72-426B-40E8-8BDC-940FA2C771E5 Q49959280-32A57D9F-7666-48A6-B730-75957656BFBD

P2860

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

Item

http://www.wikidata.org/entity/Q35661283

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

@ast

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

@en

type

Item

label

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

@ast

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

@en

prefLabel

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

@ast

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

@en

P1476

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

@en

P2093

Jie Ding

http://www.w3.org/2001/XMLSchema#string

Juan Li

http://www.w3.org/2001/XMLSchema#string

Juan Wang

http://www.w3.org/2001/XMLSchema#string

Keming Wang

http://www.w3.org/2001/XMLSchema#string

Xuezhen Hu

http://www.w3.org/2001/XMLSchema#string

Ya Zhu

http://www.w3.org/2001/XMLSchema#string

Yan Lin

http://www.w3.org/2001/XMLSchema#string

Ye He

http://www.w3.org/2001/XMLSchema#string

Yongguo Shi

http://www.w3.org/2001/XMLSchema#string

P2860

AKT/PKB signaling: navigating downstream

Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells

Cancer statistics, 2010

Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1

Label-free recognition of drug resistance via impedimetric screening of breast cancer cells

The protein kinase B/Akt signalling pathway in human malignancy

The prevalence and correlates of breast cancer among women in Eastern China

A marine anthraquinone SZ-685C overrides adriamycin-resistance in breast cancer cells through suppressing Akt signaling

Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery.

Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquired.

P2888

s12906-015-0710-8

P304

181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12906-015-0710-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278041054

http://www.w3.org/2001/XMLSchema#string

P6179

1027504591

http://www.w3.org/2001/XMLSchema#string

P698

26066793

http://www.w3.org/2001/XMLSchema#string

P932

4486132

http://www.w3.org/2001/XMLSchema#string

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

about

P2860

P2860

Gambogenic acid alters chemosensitivity of breast cancer cells to Adriamycin

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932